Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Patient Barriers for Weight Management Among African American Women.

Bowie O, Kusch J, Morris GL 3rd, Flood T, Gill J, Walker RE, Cisler RA, Fink JT.

J Patient Cent Res Rev. 2018 Oct 29;5(4):287-297. doi: 10.17294/2330-0698.1643. eCollection 2018 Fall.

2.

Effect of dietary fat supplementation on methane emissions from dairy cows fed wheat or corn.

Alvarez-Hess PS, Williams SRO, Jacobs JL, Hannah MC, Beauchemin KA, Eckard RJ, Wales WJ, Morris GL, Moate PJ.

J Dairy Sci. 2019 Mar;102(3):2714-2723. doi: 10.3168/jds.2018-14721. Epub 2019 Jan 17.

PMID:
30660414
3.

Cyclical Sweating Caused by Temporal Lobe Seizures.

Chelmowski MK, Morris GL 3rd.

Ann Intern Med. 2019 Jun 4;170(11):813-814. doi: 10.7326/L18-0425. Epub 2019 Jan 15. No abstract available.

PMID:
30641546
4.

Adaptation responses in milk fat yield and methane emissions of dairy cows when wheat was included in their diet for 16 weeks.

Moate PJ, Jacobs JL, Hannah MC, Morris GL, Beauchemin KA, Alvarez Hess PS, Eckard RJ, Liu Z, Rochfort S, Wales WJ, Williams SRO.

J Dairy Sci. 2018 Aug;101(8):7117-7132. doi: 10.3168/jds.2017-14334. Epub 2018 May 3.

5.

Influence of feeding supplements of almond hulls and ensiled citrus pulp on the milk production, milk composition, and methane emissions of dairy cows.

Williams SRO, Chaves AV, Deighton MH, Jacobs JL, Hannah MC, Ribaux BE, Morris GL, Wales WJ, Moate PJ.

J Dairy Sci. 2018 Mar;101(3):2072-2083. doi: 10.3168/jds.2017-13440. Epub 2017 Dec 28.

6.

Physician Use of Electronic Health Records in Obesity Management.

Morris GL 3rd, Chapman K, Nelson D, Fink J, Walker R, Cisler RA.

WMJ. 2016 Jun;115(3):140-2.

7.

Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the guideline development subcommittee of the american academy of neurology.

Morris GL 3rd, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C.

Epilepsy Curr. 2013 Nov;13(6):297-303. doi: 10.5698/1535-7597-13.6.297.

8.

Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Morris GL 3rd, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C.

Neurology. 2013 Oct 15;81(16):1453-9. doi: 10.1212/WNL.0b013e3182a393d1. Epub 2013 Aug 28. Review.

9.

Tiagabine in clinical practice: effects on seizure control and behavior.

Vossler DG, Morris GL 3rd, Harden CL, Montouris G, Faught E, Kanner AM, Fix A, French JA; Postmarketing Antiepileptic Drug Survey (PADS) group study investigators.

Epilepsy Behav. 2013 Aug;28(2):211-6. doi: 10.1016/j.yebeh.2013.05.006. Epub 2013 Jun 13.

PMID:
23770680
10.

Alternative therapeutic options for medical management of epilepsy in apes.

Gerlach T, Clyde VL, Morris GL 3rd, Bell B, Wallace RS.

J Zoo Wildl Med. 2011 Jun;42(2):291-4.

PMID:
22946407
11.

Unexpected right hemisphere language representation identified by the intracarotid amobarbital procedure in right-handed epilepsy surgery candidates.

Cunningham JM, Morris GL 3rd, Drea LA, Kroll JL.

Epilepsy Behav. 2008 Jul;13(1):139-43. doi: 10.1016/j.yebeh.2008.02.019. Epub 2008 Apr 18.

PMID:
18396109
12.

Predictors of naming decline after dominant temporal lobectomy: age at onset of epilepsy and age of word acquisition.

Ruff IM, Swanson SJ, Hammeke TA, Sabsevitz D, Mueller WM, Morris GL.

Epilepsy Behav. 2007 Mar;10(2):272-7. Epub 2007 Jan 31.

PMID:
17270499
13.

Reproductive and sexual dysfunction in men with epilepsy.

Montouris G, Morris GL 3rd.

Epilepsy Behav. 2005 Dec;7 Suppl 2:S7-14. Epub 2005 Oct 20. Review.

PMID:
16243004
14.

Human sexuality, sex hormones, and epilepsy.

Morris GL 3rd, Vanderkolk C.

Epilepsy Behav. 2005 Dec;7 Suppl 2:S22-8. Epub 2005 Oct 20. Review.

PMID:
16243001
15.

Nasofacial zygomycosis: a case report of conidiobolus coronatus in a Hispanic immigrant in South Carolina.

deMent SH, Davis MS, Morris GL, Langmo MG, Scates KW.

J S C Med Assoc. 2005 Apr;101(4):93-6. No abstract available.

PMID:
16095027
16.

Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center.

Spanaki MV, Allen LS, Mueller WM, Morris GL 3rd.

Seizure. 2004 Dec;13(8):587-90.

17.

Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.

Morris GL, Hammer AE, Kustra RP, Messenheimer JA.

Epilepsy Behav. 2004 Aug;5(4):509-12.

PMID:
15256187
19.

Lateralising value of ictal features in partial seizures: effect on postsurgical outcome.

Alsaadi TM, Morris GL, Mueller WM.

Seizure. 2003 Jul;12(5):257-60.

20.

Observations on the use of vagus nerve stimulation earlier in the course of pharmacoresistant epilepsy: patients with seizures for six years or less.

Helmers SL, Griesemer DA, Dean JC, Sanchez JD, Labar D, Murphy JV, Bettis D, Park YD, Shuman RM, Morris GL 3rd.

Neurologist. 2003 May;9(3):160-4.

PMID:
12808412
21.

Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery.

Sabsevitz DS, Swanson SJ, Hammeke TA, Spanaki MV, Possing ET, Morris GL 3rd, Mueller WM, Binder JR.

Neurology. 2003 Jun 10;60(11):1788-92.

PMID:
12796532
22.

Psychological Treatment of Nonepileptic Events.

Rusch MD, Morris GL, Allen L, Lathrop L.

Epilepsy Behav. 2001 Jun;2(3):277-283.

PMID:
12609370
23.

Reply.

Dodrill CB, Morris GL.

Epilepsy Behav. 2001 Apr;2(2):162. No abstract available.

PMID:
12609202
24.

Effects of Vagal Nerve Stimulation on Cognition and Quality of Life in Epilepsy.

Dodrill CB, Morris GL.

Epilepsy Behav. 2001 Feb;2(1):46-53.

PMID:
12609181
25.

Tiagabine overdose can induce convulsive status epilepticus.

Ostrovskiy D, Spanaki MV, Morris GL 3rd.

Epilepsia. 2002 Jul;43(7):773-4. No abstract available.

26.

fMRI in patients implanted with a vagal nerve stimulator.

Sucholeiki R, Alsaadi TM, Morris GL 3rd, Ulmer JL, Biswal B, Mueller WM.

Seizure. 2002 Apr;11(3):157-62.

27.

Memory outcome after left anterior temporal lobectomy in patients with expected and reversed Wada memory asymmetry scores.

Sabsevitz DS, Swanson SJ, Morris GL, Mueller WM, Seidenberg M.

Epilepsia. 2001 Nov;42(11):1408-15.

28.

Postmarketing experience with topiramate and cognition.

Tatum WO 4th, French JA, Faught E, Morris GL 3rd, Liporace J, Kanner A, Goff SL, Winters L, Fix A; PADS Investigators. Post-marketing antiepileptic drug survey.

Epilepsia. 2001 Sep;42(9):1134-40.

29.

Magnetic resonance analysis of postsurgical temporal lobectomy.

Alsaadi TM, Ulmer JL, Mitchell MJ, Morris GL, Swanson SJ, Mueller WM.

J Neuroimaging. 2001 Jul;11(3):243-7.

PMID:
11462289
31.

Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures.

DeGiorgio CM, Schachter SC, Handforth A, Salinsky M, Thompson J, Uthman B, Reed R, Collins S, Tecoma E, Morris GL, Vaughn B, Naritoku DK, Henry T, Labar D, Gilmartin R, Labiner D, Osorio I, Ristanovic R, Jones J, Murphy J, Ney G, Wheless J, Lewis P, Heck C.

Epilepsia. 2000 Sep;41(9):1195-200.

32.

Vagus nerve stimulation therapy for epilepsy in older adults.

Sirven JI, Sperling M, Naritoku D, Schachter S, Labar D, Holmes M, Wilensky A, Cibula J, Labiner DM, Bergen D, Ristanovic R, Harvey J, Dasheiff R, Morris GL, O'Donovan CA, Ojemann L, Scales D, Nadkarni M, Richards B, Sanchez JD.

Neurology. 2000 Mar 14;54(5):1179-82.

PMID:
10720294
33.

Oxcarbazepine in a monotherapy trial for partial seizures--placebo-controlled studies in neurology: where do they stop?

Schachter SC, Vazquez B, Fisher RS, Laxer KD, Combs-Cantrell D, Faught E, Willmore LJ, Morris GL, Ojemann L, Montouris GD.

Neurology. 1999 Dec 10;53(9):2211-2. No abstract available.

PMID:
10599816
34.

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

Morris GL 3rd, Mueller WM.

Neurology. 1999 Nov 10;53(8):1731-5. Erratum in: Neurology 2000 Apr 25;54(8):1712.

PMID:
10563620
35.

Language dominance in neurologically normal and epilepsy subjects: a functional MRI study.

Springer JA, Binder JR, Hammeke TA, Swanson SJ, Frost JA, Bellgowan PS, Brewer CC, Perry HM, Morris GL, Mueller WM.

Brain. 1999 Nov;122 ( Pt 11):2033-46.

PMID:
10545389
36.

Gabapentin.

Morris GL.

Epilepsia. 1999;40 Suppl 5:S63-70. Review.

37.

Payer costs of patients diagnosed with epilepsy.

Griffiths RI, Schrammel PN, Morris GL, Wills SH, Labiner DM, Strauss MJ.

Epilepsia. 1999 Mar;40(3):351-8.

38.

Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures.

Schachter SC, Vazquez B, Fisher RS, Laxer KD, Montouris GD, Combs-Cantrell DT, Faught E, Willmore LJ, Morris GL, Ojemann L, Bennett D, Mesenbrink P, D'Souza J, Kramer L.

Neurology. 1999 Mar 10;52(4):732-7.

PMID:
10078718
39.

Is speech arrest during wada testing a valid method for determining hemispheric representation of language?

Benbadis SR, Binder JR, Swanson SJ, Fischer M, Hammeke TA, Morris GL, Frost JA, Springer JA.

Brain Lang. 1998 Dec;65(3):441-6.

PMID:
9843613
40.

Clinical utility of sleep-deprived versus computer-assisted ambulatory 16-channel EEG in epilepsy patients: a multi-center study.

Liporace J, Tatum W 4th, Morris GL 3rd, French J.

Epilepsy Res. 1998 Nov;32(3):357-62.

PMID:
9839775
41.

Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm.

Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Ho KC, Jaradeh SS, Meyer GA, Blindauer KA, Cusick JF, Morris GL, Walsh PR.

AJNR Am J Neuroradiol. 1998 Oct;19(9):1695-703.

42.

Side of seizure focus predicts left medial temporal lobe activation during verbal encoding.

Bellgowan PS, Binder JR, Swanson SJ, Hammeke TA, Springer JA, Frost JA, Mueller WM, Morris GL.

Neurology. 1998 Aug;51(2):479-84.

PMID:
9710022
43.

Fulminant progression of demyelinating disease after valproate-induced encephalopathy.

Blindauer KA, Harrington G, Morris GL 3rd, Ho KC.

Neurology. 1998 Jul;51(1):292-5.

PMID:
9674826
44.

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial.

Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW.

Neurology. 1998 Jul;51(1):48-55.

PMID:
9674777
45.

Hemispheric language dominance studied with functional MR: preliminary study in healthy volunteers and patients with epilepsy.

van der Kallen BF, Morris GL, Yetkin FZ, van Erning LJ, Thijssen HO, Haughton VM.

AJNR Am J Neuroradiol. 1998 Jan;19(1):73-7.

46.

Functional MR activation correlated with intraoperative cortical mapping.

Yetkin FZ, Mueller WM, Morris GL, McAuliffe TL, Ulmer JL, Cox RW, Daniels DL, Haughton VM.

AJNR Am J Neuroradiol. 1997 Aug;18(7):1311-5.

47.

The clinical utility of computer-assisted ambulatory 16 channel EEG.

Morris GL.

J Med Eng Technol. 1997 Mar-Apr;21(2):47-52.

PMID:
9131447
48.

Totally automated analysis by robotized PrepStation and liquid chromatography: direct-sample analysis of felbamate.

Wong SH, Sasse EA, Schroeder JM, Rodgers JK, Pearson ML, Neicheril JC, Radewahn KL, Morris GL.

Ther Drug Monit. 1996 Oct;18(5):573-80.

PMID:
8885122
49.

Functional magnetic resonance imaging mapping of the motor cortex in patients with cerebral tumors.

Mueller WM, Yetkin FZ, Hammeke TA, Morris GL 3rd, Swanson SJ, Reichert K, Cox R, Haughton VM.

Neurosurgery. 1996 Sep;39(3):515-20; discussion 520-1.

PMID:
8875481
50.

Determination of language dominance using functional MRI: a comparison with the Wada test.

Binder JR, Swanson SJ, Hammeke TA, Morris GL, Mueller WM, Fischer M, Benbadis S, Frost JA, Rao SM, Haughton VM.

Neurology. 1996 Apr;46(4):978-84.

PMID:
8780076

Supplemental Content

Loading ...
Support Center